Armenia–EU Comprehensive and Enhanced Partnership Agreement

PharmAla Partners with Clariti Strategic Advisors™

Retrieved on: 
Wednesday, November 8, 2023
MDMA, OTC, Research, Armenia–EU Comprehensive and Enhanced Partnership Agreement, CSE, Partnership, MDXX, RSU, Pharmaceutical industry, Security (finance), Clarity Capital

VANCOUVER, British Columbia, Nov. 08, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research, development and manufacturing of novel MDXX class molecules (including MDMA), is proud to announce that it has signed an exclusive long-term agreement (the “Partnership Agreement”) with Clariti Strategic Advisors Inc. (“Clariti”) of Toronto, pursuant to which Clariti will provide strategic advisory and investment banking services to the Company.

Key Points: 
  • VANCOUVER, British Columbia, Nov. 08, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research, development and manufacturing of novel MDXX class molecules (including MDMA), is proud to announce that it has signed an exclusive long-term agreement (the “Partnership Agreement”) with Clariti Strategic Advisors Inc. (“Clariti”) of Toronto, pursuant to which Clariti will provide strategic advisory and investment banking services to the Company.
  • Clariti will provide advice to help PharmAla ensure that its long-term value to its stakeholders is at all times being considered and optimized.
  • Clariti, its subsidiaries and sub-agents will also advise as needed on: (i) the raising of capital through strategic investments at the corporate or subsidiary/joint venture level, (ii) significant/strategic investments by PharmAla, (iii) joint venture arrangements, (iv) mergers and acquisitions, and (v) the negotiation of strategic customer licensing or supply agreements.
  • We are proud to work with Clariti as our exclusive strategic advisor and investment banking partner moving forward,” said Nick Kadysh, CEO, PharmAla.

Winners of the 31st edition Lorenzo Natali Media Prize

Retrieved on: 
Thursday, October 12, 2023
Lorenzo Natali Media Prize, Prize, Partnership, International Prize for Arabic Fiction, Thomson Reuters Foundation, Climate change, Best, Solvay, International Prize (Fyssen Foundation), IStories, Risk, Jordan Media Institute, European Commission, University, Michelin, Freedom, Pulitzer Prize, Education, Portuguesa, Poverty, Environment, International, British University in Dubai, Non-governmental organization, Civil service commission, Media, Rainforest, Vesalius College, Armenia–EU Comprehensive and Enhanced Partnership Agreement, Journalism, Rape, Brazilian Association of Investigative Journalism, Auction, Renewable energy, Management, Voxeurop, EU

The winners of this year's edition of the Lorenzo Natali Media Prize, awarded by the European Commission, were announced at a ceremony hosted at the Solvay Library in Brussels.

Key Points: 
  • The winners of this year's edition of the Lorenzo Natali Media Prize, awarded by the European Commission, were announced at a ceremony hosted at the Solvay Library in Brussels.
  • Their work exposed the harrowing reality of systematic persecution in Venezuela, targeting political opponents and their families with alarming impunity.
  • The 2023 winners were chosen from a pool of over 1 000 submissions from across the globe.
  • The Prize is named in honour of Lorenzo Natali, former Vice-President of the European Commission and a tireless advocate for freedom of expression and human rights.

Moon Equity Holdings to Sell BitGift Asset to Silo Wellness in Exchange for a Dividend

Retrieved on: 
Wednesday, April 26, 2023
Armenia–EU Comprehensive and Enhanced Partnership Agreement, Partnership, CSE, Aviation, CAD, Risk assessment, FSE, Social media, Interchange (road), AML, Acquisition, VWAP, Series, FINRA, OTC, Indian stock exchange, KYC, Bookkeeping, Cryptocurrency

At closing, MONI plans to allocate the Silo shares as a dividend to MONI existing shareholders, based on a record date to be determined by FINRA.

Key Points: 
  • At closing, MONI plans to allocate the Silo shares as a dividend to MONI existing shareholders, based on a record date to be determined by FINRA.
  • Moon Equity Holdings CEO, Frank Ottaviani, stated, “We are pleased to have entered into this agreement with Silo Wellness, and we are looking forward to integrating the BitGift platform into Oregon’s psilocybin market and beyond.
  • According to the terms, MONI would transfer the BitGift asset to Silo Wellness in exchange for 5,050,505 Common Shares of Silo (currently valued at CAD$100,000 as per the 20-day VWAP).
  • Mike Arnold, CEO of Silo Wellness, commented, “We see BitGift as a catalyst to swiftly move Oregon psilocybin away from a cash-only system.

MONI/BitGift® Signs Partnership With MoonPay to Provide Visa Debit Card, Onramp and Offramp Services to BitGift

Retrieved on: 
Monday, February 13, 2023
ACH, Visa, Mastercard, Acquisition, API, Apple Pay, Google Pay, Series, Risk, SEPA, KYC, Partnership, Fiat, Armenia–EU Comprehensive and Enhanced Partnership Agreement, Faster Payments, OTC, Cryptocurrency, Interchange (road)

Through the partnership, BitGift® will now be able to provide its customers the use of Visa Debit Cards, as well as Onramp and Offramp services.

Key Points: 
  • Through the partnership, BitGift® will now be able to provide its customers the use of Visa Debit Cards, as well as Onramp and Offramp services.
  • MoonPay ensures that compliance will never be an issue as it provides top notch KYC and onboarding services.
  • Once the integration is complete, BitGift® will be able to provide its users with a fully-complete Onramp and Offramp system.
  • This integration will allow BitGift® to provide a complete set of Onramp and Offramp services for its users, while also continuing to provide a trusted and secure platform for buying, selling, sending, and receiving a BitGift®.